Actively Recruiting
Altshock-2 REGISTRY
Led by Niguarda Hospital · Updated on 2026-05-14
3000
Participants Needed
1
Research Sites
600 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will provide data on profile, management, outcome, and evolution over time of cardiogenic shock patients admitted to the Intensive Coronary Care Units
CONDITIONS
Official Title
Altshock-2 REGISTRY
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with cardiogenic shock hospitalized in participating centers between January 2020 and December 2030
- Cardiogenic shock defined by systolic blood pressure less than 90 mmHg or mean arterial pressure less than 60 mmHg after fluid challenge, or need for vasoactive agents or mechanical circulatory support
- Presence of at least one sign of hypoperfusion: mixed venous oxygen saturation below 60%, arterial lactates above 2 mmol/L, or urine output less than 0.5 ml/kg/h for at least 6 hours
- Age 18 years or older
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ASST GOM Niguarda
Milan, Italy, 20125
Actively Recruiting
Research Team
A
Alice Sacco, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here